References
- Morrison JR: Changes in subtype diagnosis of schizophrenia: 1920-1966. Am J Psychiatry 1974; 131:674–677.
- Achte KA: The course of schizophrenic and schizophreniform psychosis. Acta Psychiatrica et Neurologica Scandinavica 1961; 36:224–226.
- Mahendra B: Where have all the catatonics gone? Psychol Med 1981; 11:669–671.
- Leff J: Psychiatry around the globe. London: Royal College of Psychiatrists; 1988.
- Kraepelin EA: Lectures on clinical psychiatry. London: Bail-here, Tindall and Cox; 1904.
- Bleuler E: Dementia praecox or the group of schizophrenias (Zinkin J, trans). New York: International University Press; 1950.
- Taylor MA: Catatonia: A review of a behavioral neurologic syndrome. Neuropsych Neuropsych Behav N 1990; 3:48–72.
- Morrison JR: Catatonia: prediction of outcome. Compr Psych-iat 1974; 15:317–324.
- Abrams R, Taylor MA: Catatonia: A prospective clinical study. Arch Gen Psychiatry 1976; 33:579–581.
- Pataki J, Zervas IM, Jandorf L: Catatonia in a university in-patient service (1985-1990). Convulsive Ther 1992; 8:163–170.
- American Psychiatric Association: Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: Ameri-can Psychiatric Press, 1994.
- Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF: Catatonic syndrome in a general psychiatric population: Fre-quency, clinical presentation, and response to lorazepam. J Clin Psychiatry 1990; 51:357–362.
- Ungvari GA, Leung CM, Wong MK, Lau J: Benzodiazepines in the treatment of catatonic syndrome. Acta Psychiatr Scand 1994; 89:285–288.
- Bush G, Fink M, Petrides G, Dowling F, Francis A: Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand 1996; 93:129–136.
- Lohr JB, Wisenewski AA: Movement disorders: a neuropsy-chiatric approach. New York, NY: Guilford Press, 1987.
- Bush G, Fink M, Petrides G, Dowling F, Francis A: Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996; 93:137–143.
- Francis A, Divadeenam K, Bush G, Petrides G: Consistency of symptoms in recurrent catatonia. Compr Psychiat 1997; 38:56–60.
- Bush G, Petrides G, Francis A: Catatonia and other motor syndromes in a chronically hospitalized psychiatric popula-tion. Schizophr Res 1997; 27:83–92.
- Fricchione GL, Cassem NH, Hooberman D, Hobson D: Intra-venous lorazepam in neuroleptic-induced catatonia. J Clin Psychopharmacol 1983; 3:338–342.
- Salem SA, Pillai AK, Beresford TP: Lorazepam for psy-chogenic catatonia. Am J Psychiatry 1987; 144:1082–1083.
- Greenfield D, Conrad C, Kincare P, Bowers MB. Jr: Treat-ment of catatonia with low-dose lorazepam. Am J Psychiatry 1987; 144:1224–1225.
- Menza MA, Harris D: Benzodiazepines and catatonia: an overview. Biol Psychiatry 1989; 26:842–846.
- Wetzel H, Heuser I, Benkert 0: Stupor and affective state: Alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after RO 15-1788. J Nerv Ment Dis 1987; 175:240–242.
- Lund CE, Mortimer AM, Rogers D, McKenna PJ: Motor, volitional and behavioural disorders in schizophrenia I: As-sessment using the modified Rogers Scale. Br J Psychiatry 1991; 158:323–327.
- Kay SR, Fiszbein A, Obler LA: The postive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987; 13:261–267.
- Simpson GM, Angus JWS: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970; 212:11–19.
- American Psychatric Association: Diagnostic and statistical manual of mental disorder, 3rd ed-Revised. Washington, DC: American Psychiatric Press, 1987.
- World Health Organization: The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992.
- Gelenberg AJ, Mandel MR: Catatonic reactions to high po-tency neuroleptic drugs. Arch Gen Psychiatry 1977; 34:947–950.
- Levenson JL: Neuroleptic malignant syndrome. Am J Psychia-try 1985; 142:1137–1145.
- Pope HG, Keck PE, McElroy SL: Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hos-pital. Am J Psychiatry 1986; 143:1227–1233.
- Mann SC, Caroff SN, Bleier HR, Welz WK, Kling MA, Hayas-hida M: Lethal catatonia. Am J Psychiatry 1986; 143:1374–1381.
- Philbrick KI, Rummans TA: Malignant catatonia. J Neuropsy-chiatry Clin Neurosci 1994; 6:1–13.
- Lee JWY: Serum iron in catatonia and neuroleptic malignant syndrome. Biol Psychiatry 1998; 44:499–507.
- Chandrasena R: Catatonic schizophrenia: An international comparative study: Can J Psychiatry 1986; 31:249–252.
- Carpenter WT, Bartko JJ, Carpenter CL, Strauss JS: Another view of schizophrenia subtypes: A report from the interna-tional pilot study of schizophrenia. Arch Gen Psychiatry 1976; 33:508–516.
- Lange J: Katatonische Erscheinungen im Rahmen manisch-depressiver Erkrankungen. Monographien aus dem Gesamt-gebiete der Neurologie und Psychiatric 31. Berlin, Germany: Springer, 1922.
- Taylor MA, Abrams R: The phenomenology of mania: A new look at some old patients. Arch Gen Psychiatry 1973; 29:520–522.
- Braunig P, Kruger S, Shugar G: Prevalence and clinical sig-nificance of catatonic symptoms in mania. Compr Psychiat 1998; 39:35–46.
- Northoff G, Demisch L, Wenke J, Pflug B: Plasma homovanil-lic acid concentrations in catatonia. Biol Psychiatry 1996; 39:436–443.